CRISPR gene-editing technology promises to be one of the most significant scientific and medical breakthroughs in modern history. Its precision and relative ease-of-use have already transformed how scientists study...
Author - Fiona Mischel
A bold strategy for saving our world
Novel nitrogen sources allow us to radically rethink how we produce food and materials for humankind. Agriculture has come a long way in the last 100 years, due in large part to the invention of synthetic nitrogen...
The CRISPR twins: bioethics for the gene-editing age
The discovery of CRISPR technology brought the bioethics of altering human DNA to the forefront. And rightly so. CRISPR is a powerful tool, potentially capable of changing who we are at our genetic core. In light of...
Farming on Mars: A future for synthetic biology off Earth
Climate change is rapidly altering the stability of our delicate ecosystem. We face the pressing challenge of providing food for almost 8 billion people even as arable land diminishes. Many scientists look to our home...
Moving to Mars? Biomaterials point the way
Synthetic biology innovations aim to change how we live on Earth. But could they also enable us to live on other planets? Scientists from iGEM teams to NASA are developing ways to make life off Earth a reality. Space...
Partnering with Procter and Gamble: Joining together to change the world
Procter and Gamble (P&G) is one of the largest influencers in the growing market aiming to serve the consumer looking for a more natural lifestyle. They are creating new products leveraging bio-based ingredients and...
Pivot Bio: Re-Awakening the Agricultural Microbiome
This story is brought to you by Pivot Bio, a company dedicated to providing farmers with solutions, so they can grow high-quality, environmentally-responsible and sustainably focused food crops that help feed families...
A Nobel Prize for Evolutionary Biology
The Nobel Prize in Chemistry was awarded yesterday to three recipients for discovering methods in controlling and speeding enzyme and antibody evolution. Frances H. Arnold, a professor of chemical engineering at the...
Bio-Platforms: The Future of Innovation and Collaboration
This article is brought to you by Mammoth Biosciences, the company behind the first CRISPR-based platform for disease detection. Mammoth Biosciences CEO Trevor Martin and Ursheet Parikh of Mayfield, a Series A investor...
Discovering DETECTR: The CRISPR-based platform for disease detection
Mammoth Biosciences is using their groundbreaking CRISPR technology—DETECTR—to revolutionize diagnostic medicine. SynBioBeta sat down with Janice Chen, one of Mammoth’s co-founders and lead author of the study that...
